Notícias e Atividades da Clearside Biomedical
Presença
Sede: Estados Unidos
Clearside Biomedical é uma empresa listada sob o símbolo CLSD (US).
Fusão, aquisição e financiamento envolvendo Clearside Biomedical.
- Clearside Biomedical has gone out of its bankruptcy protection (publicado em 15 de julho de 2026).
Executivos
Veja o organograma con seus 17 executivos principais
Biografias mais buscadas da Clearside Biomedical
- George Lasezkay, Chief Executive Officer and Director
- Christy Shaffer, Director
- Clay Thorp, Chairman of the Board
Criar um alerta
para seguir os movimentos de executivos da Clearside Biomedical.
Biotecnologia
Clearside Biomedical possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).
Popular M&A news in Biotecnologia
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado em 17 de julho de 2026).
- GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publicado em 15 de julho de 2026).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Clearside Biomedical
- Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process | Clearside Biomedical, Inc.- IR Site
- News | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting | Clearside Biomedical, Inc.- IR Site
- News | Clearside Biomedical, Inc.- IR Site
- View more press releases Close
Redes sociais sobre Clearside Biomedical
- Clearside Biomedical na Wikipedia, Google News e Yahoo Finance
- Clearside Biomedical na LinkedIn, X (Twitter) e YouTube
